Abstract:Background: Previous studies have demonstrated that Tc-99m-sestamibi (Tc-99m- MIBI) Single-Photon Emission Computed Tomography/Computed Tomography (SPECT/CT) imaging is an effective isotopic technique for locating the parathyroid in secondary hyperparathyroidism (SHPT). This study aimed to explore further the correlation between Tc-99m-MIBI SPECT/CT imaging and SHPT to demonstrate the value of Tc-99m-MIBI SPECT/CT in evaluating the degree of pathological hyperplasia of the parathyroid gland (PG). Methods: The demographics, surgical records, and follow-up information of 91 patients were recorded and analyzed. A total of 216 paraffin-embedded PGs of 54 patients were obtained and analyzed. Results: Patients with Tc-99m-MIBI negative PG(s) had significantly lower preoperative serum phosphorus and higher serum calcium levels at 6 months postoperatively compared to those with Tc-99m-MIBI positive PG(s) (P<0.05). We also found a higher total uptake ratio of the region of interest (URRI) and higher URRI max in the hypocalcemia group than in the non-hypocalcemia group. Both URRI total (P=0.003) and URRI max (P=0.028) were independent risk factors for hypocalcemia 6 months postoperatively. The URRI values of the PGs were significantly positively correlated with glandular weight (R-2=0.343, P<0.001), glandular volume (R-2=0.240, P<0.001), and degree of pathological hyperplasia (P<0.001). However, the URRI value of the PGs exhibited a notably weak correlation with proliferating cell nuclear antigen (PCNA) (R-2=0.035, P=0.006). The area under the receiver operating characteristic curve showed a URRI evaluative value of 0.771 for diffuse and nodular types in 216 PGs (P<0.001). We further evaluated 167 nodular-type PGs, distinguishing between nodular hyperplasia and a single nodule; the URRI evaluative value reached 0.819, which was higher than the volume or weight (P<0.001). Conclusions: The Tc-99m-MIBI SPECT/CT scintigraphy results were related to serum calcium levels at 6 months after total parathyroidectomy with autotransplantation (TPTX+AT), suggesting the occurrence of hypocalcemia (6 months after TPTX+AT). More importantly, this technique effectively evaluated the pathological hyperplasia of PGs preoperatively, and therefore, could assist surgeons in selecting the PGs with the lowest degree of hyperplasia intraoperatively.

Unexpected Retrosternal Goiter Interpreted As Hyperfunctioning Metastasis on the Posttherapeutic 131I SPECT/CT

Unusual Uptake of Radioiodine in a Retroperitoneal Bronchogenic Cyst in a Patient with Thyroid Carcinoma

131 I Uptake in a Left Cerebral Infarct on Posttherapy Whole-Body Scan

Thyrotoxicosis Due To Functioning Metastatic Follicular Thyroid Carcinoma After Twelve I-131 Therapies

Pathological diagnosis and immunohistochemical analysis of giant retrosternal goiter in the elderly: A case report

Concurrent Benign Iodine-Avid Thymic and Liver Cysts Mimicking Metastatic Disease on 131I Whole-Body Scintigraphy

Mediastinal accumulation of 131I in post-operative patients with thyroid cancer

Elevated 131 I Activity in Adrenal Cyst in a Patient With Thyroid Cancer

An Unusual False-Positive Uptake of Radioiodine Caused by Posttraumatic Superficial Scab

Sustained and Diffuse 131I Avid Bone Metastases with Low Thyroglobulin Levels in a Patient with Papillary Thyroid Carcinoma

Use of 99Mtc-Sestamibi SPECT/CT Imaging in Predicting the Degree of Pathological Hyperplasia of the Parathyroid Gland: Semi-Quantitative Analysis.

Unusual Achalasia Presentation Detected on 131I SPECT/CT in a Papillary Thyroid Carcinoma Patient

False-Positive Radioactive Iodine Uptake Caused by Cervical Myofascitis in a Patient with Differentiated Thyroid Carcinoma

An Unusual False-Positive Uptake of Radioiodine Caused by Breast Implants

False-Positive 131I Uptake After Transareola Endoscopic Thyroidectomy in a Patient With Papillary Thyroid Carcinoma

Unusual Achalasia Presentation Detected on 131 I SPECT/CT in a Papillary Thyroid Carcinoma Patient

Nabothian Cyst Associated With High False-Positive Incidence Of Iodine-131 Uptake In Whole-Body Scans After Treatment For Differentiated Thyroid Cancer

An Unusual 131I-Avid Adrenal Metastasis from Follicular Thyroid Carcinoma Identified by 131I-SPECT/CT.

Follow-up of a case of subacute thyroiditis with uncommon thyroid (99m)Tc uptake.

False-Positive Uptake of 131I Due to Tubal Ligation in a Patient with Papillary Thyroid Cancer.